Abstract:We retrospectively analyzed the clinical data of seven patients (four men and three women) with primary hyperoxaluria (PH) type 1 (PH1) in the Department of Nephrology of Zhongda Hospital, Southeast University from January 2018 to October 2023. The mean age at disease onset was 32.1 (range: 26-42) years. The mean age at diagnosis was 40.6 (range: 28-51) years. All patients initially had kidney stones, and three patients were found to have renal insufficiency at the time of disease onset. Among them, two patients underwent hemodialysis immediately. Symptoms at the first visit included bone pain (n=7), joint pain or deformity (n=5), fatigue (n=5), hypotension (n=3), and subcutaneous nodules (n=2). Four patients had a family history of PH. All patients had varying degrees of anemia (60-114 g/L), significant hypoalbuminemia (16.5-32.1 g/L), and hypercoagulable state (D-dimer: 2 230-12 781 μg/L). Seven patients received maintenance hemodialysis; their mean age was 37.7 (range: 26-50) years. The mean duration from disease onset to hemodialysis was 5.6 (range: 0-20) years. Five patients repeatedly experienced dialysis access dysfunction. Three patients underwent kidney transplantation before a diagnosis was made, and all transplanted kidneys lost function due to oxalate deposition. The mean follow-up duration was 14.43 (range: 4-38) months. Unfortunately, one patient died. All seven patients underwent computed tomography of the abdomen. All patients suffered skeletal abnormalities, bilateral nephrolithiasis, and nephrocalcinosis. Six patients carried AGXT gene mutations, including four compound heterozygous mutations and two pure homozygous mutations.The mutation sites included: c.823-824dup.AG (p.S275Rfs*38)(exon 8), c.815-816ins.GA (p.S275Rfs*38)(exon 8), c.595G>A (p.G199S) (exon 5), c.32C>G (p.P11R) (exon 1), and c.638C>T (p.A213V)(exon 6). According to the American College of Medical Genetics and Genomics guidelines, two loci were identified as likely pathogenic variants, seven were identified as pathogenic variants, and one locus was identified as having uncertain significance. In addition, patients 1 and 4 underwent skin biopsy, patient 2 underwent renal transplant biopsy, and patient 3 underwent bone marrow biopsy. Interestingly, significant oxalate deposition was found in the tissues. Therefore, PH1 is a rare autosomal recessive inherited disease. This study not only enhanced the understanding of the clinical characteristics of PH1 patients but also had great significance in early diagnosis and treatment of the disease.

Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population.

Nine Novel HOGA1 Gene Mutations Identified in Primary Hyperoxaluria Type 3 and Distinct Clinical and Biochemical Characteristics in Chinese Children

A Putative Mutation Hotspot of the AGXT Gene Associated with Primary Hyperoxaluria Type 1 in the Chinese Population

Mutation Characteristics of Primary Hyperoxaluria in the Chinese Population and Current International Diagnosis and Treatment Status

Updated Genetic Testing of Primary Hyperoxaluria Type 1 in a Chinese Population: Results from a Single Center Study and a Systematic Review

Identification of 8 Novel Gene Variants in Primary Hyperoxaluria in 21 Chinese Children with Urinary Stones.

Mutational analysis of AGXT in two Chinese families with primary hyperoxaluria type 1

Mutations in Patients with Hyperphenylalaninemia in Zhejiang, China

Mutational Analysis of AGXTin Two Chinese Families with Primary Hyperoxaluria Type 1

HOGA1 gene pathogenic variants in Primary Hyperoxaluria type III: Spectrum of pathogenic sequence variants, and phenotypic association

Three Novel Mutations in the SLCO2A1 Gene in Two Chinese Families with Primary Hypertrophic Osteoarthropathy.

Clinical features and mutational spectrum of Chinese patients with primary hyperoxaluria type 2

[Clinical analysis of seven cases of primary hyperoxaluria type 1]

Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.

Primary hyperoxaluria type 1 in one child and literature review

Mutations in DHDPSL are responsible for primary hyperoxaluria type III

Variable presentation of primary hyperoxaluria type 1 in 2 patients homozygous for a novel combined deletion and insertion mutation in exon 8 of the AGXT gene

Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations

Targeted Exome Sequencing Identified a Novel Mutation Hotspot and a Deletion in Chinese Primary Hypertrophic Osteoarthropathy Patients.

A novel mutation of human liver alanine:glyoxylate aminotransferase causes primary hyperoxaluria type Ⅰ in PH1 family

Identification of Two Novel Mutations in the Slco2a1 Prostaglandin Transporter Gene in A Chinese Patient with Primary Hypertrophic Osteoarthropathy